A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
about
Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaTracking genomic cancer evolution for precision medicine: the lung TRACERx studyTumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.Upregulation of KIN17 is associated with non-small cell lung cancer invasivenessPrognostic factors in resected lung carcinomas.Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I diseaseImplementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should knowThe cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalThe tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markersTumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinomaUsing frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutationInhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitorsNuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltrationComprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinomaInvasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients.Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.Deciduoid mesothelioma: report of 21 cases with review of the literature.Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.Classification of different patterns of pulmonary adenocarcinomas.Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies.KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.Primary adenocarcinoma of the lung--histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma.Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells.Tumor cell proliferation, proliferative index and mitotic count in lung cancer.What is better/reliable, mitosis counting or Ki67/MIB1 staining?Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.
P2860
Q27009370-70123722-B3B4-4097-9556-C97F508ED9D9Q28303718-4E154184-ABCC-4522-B660-3D28F4022913Q28655985-E10A4175-0384-476E-AC6A-EE6926260F9DQ30652903-729BE096-217C-48A9-98E8-B3EFAF31816EQ33582932-A2F685F5-A2EA-4B7E-9C88-13648B4C8064Q33597902-0DFAF4E5-3FD4-450A-9C90-958B28E0DF2CQ33697964-69D6E13F-84AF-4781-AD89-3974AA4E95B4Q34181641-7545EED4-B673-43FD-9137-14E27E86F4FBQ34404229-BF1E4E3B-8D8A-4D3A-93EB-8EE16C8ACF94Q34748124-EAF4BE2C-2B10-4334-9005-42B3BF7B9342Q35219157-2430AC81-7D3E-43EC-B42E-BD52B75AA1D1Q35678741-AFAD3B48-7AB6-403F-8637-07936FC25F8BQ35742165-44093213-8051-43C8-86EB-829A9D82C4CDQ35799028-18A4D95E-C107-4445-983C-A950987A0CE8Q35845212-ADCB66E0-8AE6-4D7A-AFC4-1BB1032615A7Q35880415-D405F262-55FC-4A42-AEF2-4B8914C3F336Q35940727-7AB8C570-B523-4F13-A015-EDC1B2F0DD77Q35954585-4B8386D1-5AFB-42AE-AFEA-7CB40081E699Q36015463-471BC20C-9DFE-4313-9734-77A61E074D65Q36337437-D5A31425-51A4-4FB8-BB75-636FE2EA69DDQ36346942-88EB1788-1FBA-4FDF-BFB4-30EFFF7B4BF0Q36413817-592568BD-593D-4552-80AB-41C041D7A2DEQ36726239-E9E74845-A48F-41DD-A581-ECABA594E005Q36952749-18C03F6E-3FC4-4373-8D73-F22DE38C4D7DQ37176131-3B7C3E9D-32F3-4A11-88DB-436CBC985F3EQ37280912-0C7D7CAB-A576-4526-9A44-6AE49753AE76Q37376521-9B728282-F6F8-4341-9C2F-E3A1BB7FDC8BQ38017572-27DDF97E-AC6A-40C8-86B2-379D661E9814Q38207553-B49EE3DE-107C-4E0B-B741-E85DC7427591Q38574971-288867C6-2F28-4E80-B070-A761AB932DAFQ38841094-94733F13-38A4-4888-944D-4295AA1DB133Q40270889-F4B5F3AC-2940-497B-9C9F-B8D944B3E240Q40542208-52E8408C-7BFD-409D-B8F2-472C5CDE9C73Q40812047-2BA3850A-F8AB-45FF-8852-91467880F9FFQ40864750-A350B79B-89B9-492E-8835-265787FE1EEBQ41627914-D76108E7-2B0F-430E-BC31-AE0CB3B535FEQ42372532-4AEA1B7B-14E6-4C10-9DF2-D558C239BFD8Q42372536-DF4D317D-35C0-4D29-9E56-63082F345FBDQ45276482-34E6861A-1C2B-4494-A61A-45B75425C8BEQ45943784-956B8A0E-931C-4D49-A609-94CD01AB8137
P2860
A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A grading system combining arc ...... n stage I lung adenocarcinoma.
@ast
A grading system combining arc ...... n stage I lung adenocarcinoma.
@en
type
label
A grading system combining arc ...... n stage I lung adenocarcinoma.
@ast
A grading system combining arc ...... n stage I lung adenocarcinoma.
@en
prefLabel
A grading system combining arc ...... n stage I lung adenocarcinoma.
@ast
A grading system combining arc ...... n stage I lung adenocarcinoma.
@en
P2093
P2860
P1433
P1476
A grading system combining arc ...... n stage I lung adenocarcinoma.
@en
P2093
Akihiko Yoshizawa
Andre L Moreira
Camelia S Sima
Emily C Zabor
Gregory J Riely
Kei Suzuki
Kyuichi Kadota
Prasad S Adusumilli
Stefan S Kachala
Valerie W Rusch
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.58
P577
2012-04-13T00:00:00Z
P5875
P6179
1051896844